Literature DB >> 19183262

Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice.

Tiziana Genovese1, Emanuela Esposito, Emanuela Mazzon, Rosanna Di Paola, Rocco Caminiti, Placido Bramanti, Alessandro Cappelani, Salvatore Cuzzocrea.   

Abstract

Interleukin-10 (IL-10) exerts a wide spectrum of regulatory activities in the immune and inflammatory response. The aim of this study was to investigate the role of endogenous IL-10 on the modulation of the secondary events in mice subjected to spinal cord injury induced by the application of vascular clips (force of 24 g) to the dura via a four-level T5-T8 laminectomy. IL-10 wild-type mice developed severe spinal cord damage characterized by oedema, tissue damage and apoptosis (measured by Annexin-V, terminal deoxynucleotidyltransferase-mediated UTP end labeling staining, Bax, Bcl-2, and Fas-L expression). Immunohistochemistry demonstrated a marked increase of localization of TNF-alpha, IL-1beta and S100beta, while western blot analysis shown an increased immunoreactivity of inducible nitric oxide synthase in the spinal cord tissues. The absence of IL-10 in IL-10 KO mice resulted in a significant augmentation of all the above described parameters. We have also demonstrated that the genetic absence of IL-10 worsened the recovery of limb function when compared with IL-10 wild-type mice group (evaluated by motor recovery score). Taken together, our results clearly demonstrate that the presence of IL-10 reduces the development of inflammation and tissue injury events associated with spinal cord trauma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19183262     DOI: 10.1111/j.1471-4159.2009.05899.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  28 in total

1.  IL-10 deficiency exacerbates the brain inflammatory response to permanent ischemia without preventing resolution of the lesion.

Authors:  Isabel Pérez-de Puig; Francesc Miró; Angélica Salas-Perdomo; Ester Bonfill-Teixidor; Maura Ferrer-Ferrer; Leonardo Márquez-Kisinousky; Anna M Planas
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-11       Impact factor: 6.200

2.  Neuroprotective effect of ginseng against spinal cord injury induced oxidative stress and inflammatory responses.

Authors:  Wei Wang; Hao Shen; Jing-Jing Xie; Jian Ling; Hua Lu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Inflammatory consequences in a rodent model of mild traumatic brain injury.

Authors:  J Regino Perez-Polo; Harriet C Rea; Kathia M Johnson; Margaret A Parsley; Geda C Unabia; Guojing Xu; Smitha K Infante; Douglas S Dewitt; Claire E Hulsebosch
Journal:  J Neurotrauma       Date:  2013-05-06       Impact factor: 5.269

Review 4.  Role of Microglial Activation in the Pathophysiology of Bacterial Meningitis.

Authors:  Tatiana Barichello; Jaqueline S Generoso; Lutiana R Simões; Jessica A Goularte; Fabricia Petronilho; Priyanka Saigal; Marwa Badawy; João Quevedo
Journal:  Mol Neurobiol       Date:  2015-03-07       Impact factor: 5.590

5.  The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury.

Authors:  Fei Qiao; Carl Atkinson; Mark S Kindy; Anandakumar Shunmugavel; B Paul Morgan; Hongbin Song; Stephen Tomlinson
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

6.  Inducible protein-10, a potential driver of neurally controlled interleukin-10 and morbidity in human blunt trauma.

Authors:  Akram M Zaaqoq; Rami Namas; Khalid Almahmoud; Nabil Azhar; Qi Mi; Ruben Zamora; David M Brienza; Timothy R Billiar; Yoram Vodovotz
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

Review 7.  Efficacy of some non-conventional herbal medications (sulforaphane, tanshinone IIA, and tetramethylpyrazine) in inducing neuroprotection in comparison with interleukin-10 after spinal cord injury: A meta-analysis.

Authors:  Davood Koushki; Sahar Latifi; Abbas Norouzi Javidan; Marzieh Matin
Journal:  J Spinal Cord Med       Date:  2014-06-26       Impact factor: 1.985

8.  Age decreases macrophage IL-10 expression: Implications for functional recovery and tissue repair in spinal cord injury.

Authors:  Bei Zhang; William M Bailey; Kaitlyn J Braun; John C Gensel
Journal:  Exp Neurol       Date:  2015-08-08       Impact factor: 5.330

9.  Lentiviral Interleukin-10 Gene Therapy Preserves Fine Motor Circuitry and Function After a Cervical Spinal Cord Injury in Male and Female Mice.

Authors:  Emily J Fu; Paras R Patel; Jessica Y Chen; Alexander J Hostetler; Hasan A Sawan; Kayla A Moss; Sarah E Hocevar; Aileen J Anderson; Cynthia A Chestek; Lonnie D Shea
Journal:  Neurotherapeutics       Date:  2020-10-13       Impact factor: 7.620

10.  Inhibition of miR-145-5p Reduces Spinal Cord Injury-Induced Inflammatory and Oxidative Stress Responses via Affecting Nurr1-TNF-α Signaling Axis.

Authors:  Lei Jiang; Zeng-Chun Wei; Li-Li Xu; Shan-Ying Yu; Chao Li
Journal:  Cell Biochem Biophys       Date:  2021-06-16       Impact factor: 2.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.